Similarly, autophagy is essential for degradation of BCR-ABL fusion protein by ATO in CML, and the inhibitory effects of ATO on colony-forming ability is reduced by lysosome inhibitors [40]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.